248 related articles for article (PubMed ID: 18781861)
1. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
Tsai SJ; Hong CJ; Liou YJ
Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
[TBL] [Abstract][Full Text] [Related]
2. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
[TBL] [Abstract][Full Text] [Related]
4. A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.
Real E; Gratacòs M; Soria V; Escaramís G; Alonso P; Segalàs C; Bayés M; de Cid R; Menchón JM; Estivill X
Biol Psychiatry; 2009 Oct; 66(7):674-80. PubMed ID: 19589503
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
Kozisek ME; Middlemas D; Bylund DB
Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
[TBL] [Abstract][Full Text] [Related]
8. Critical role of brain-derived neurotrophic factor in mood disorders.
Hashimoto K; Shimizu E; Iyo M
Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania.
Zai G; Mundo E; Strauss J; Wong GW; Kennedy JL
Bipolar Disord; 2007 Aug; 9(5):521-5. PubMed ID: 17680923
[TBL] [Abstract][Full Text] [Related]
10. [Major depressive disorders and BDNF (brain-derived neurotrophic factor)].
Shimizu E; Hashimoto K; Iyo M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):147-50. PubMed ID: 15291244
[TBL] [Abstract][Full Text] [Related]
11. Effects of antidepressant treatment on mice lacking brain-derived neurotrophic factor expression through promoter IV.
Sakata K; Mastin JR; Duke SM; Vail MG; Overacre AE; Dong BE; Jha S
Eur J Neurosci; 2013 Jun; 37(11):1863-74. PubMed ID: 23406189
[TBL] [Abstract][Full Text] [Related]
12. The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder.
de Aguiar Ferreira A; Neves FS; Pimenta GJ; Mello MP; Miranda DM; Romano-Silva MA; De Marco LA; Corrêa H
Psychiatry Res; 2010 Nov; 180(1):54-6. PubMed ID: 20483468
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.
Hashimoto K
Psychiatry Clin Neurosci; 2010 Aug; 64(4):341-57. PubMed ID: 20653908
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
Tsai SJ
Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
[TBL] [Abstract][Full Text] [Related]
15. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.
Kang RH; Chang HS; Wong ML; Choi MJ; Park JY; Lee HY; Jung IK; Joe SH; Kim L; Kim SH; Kim YK; Han CS; Ham BJ; Lee HJ; Ko YH; Lee MS; Lee MS
J Psychopharmacol; 2010 Dec; 24(12):1755-63. PubMed ID: 19493959
[TBL] [Abstract][Full Text] [Related]
17. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
18. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants.
Tsai SJ
Med Hypotheses; 2005; 65(5):942-6. PubMed ID: 16002234
[TBL] [Abstract][Full Text] [Related]
20. The brain derived neurotrophic factor and influences of stress in depression.
Kimpton J
Psychiatr Danub; 2012 Sep; 24 Suppl 1():S169-71. PubMed ID: 22945215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
